JP2006505559A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505559A5
JP2006505559A5 JP2004544204A JP2004544204A JP2006505559A5 JP 2006505559 A5 JP2006505559 A5 JP 2006505559A5 JP 2004544204 A JP2004544204 A JP 2004544204A JP 2004544204 A JP2004544204 A JP 2004544204A JP 2006505559 A5 JP2006505559 A5 JP 2006505559A5
Authority
JP
Japan
Prior art keywords
indole
benzenesulfonyl
piperazin
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004544204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505559A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/011323 external-priority patent/WO2004035047A1/en
Publication of JP2006505559A publication Critical patent/JP2006505559A/ja
Publication of JP2006505559A5 publication Critical patent/JP2006505559A5/ja
Pending legal-status Critical Current

Links

JP2004544204A 2002-10-18 2003-10-13 5−ht6受容体親和性を持つ4−ピペラジニルベンゼンスルホニルインドール Pending JP2006505559A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41936902P 2002-10-18 2002-10-18
PCT/EP2003/011323 WO2004035047A1 (en) 2002-10-18 2003-10-13 4-piperazinyl benzenesulfonyl indoles with 5-ht6 receptor affinity

Publications (2)

Publication Number Publication Date
JP2006505559A JP2006505559A (ja) 2006-02-16
JP2006505559A5 true JP2006505559A5 (cg-RX-API-DMAC7.html) 2006-11-30

Family

ID=32108067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004544204A Pending JP2006505559A (ja) 2002-10-18 2003-10-13 5−ht6受容体親和性を持つ4−ピペラジニルベンゼンスルホニルインドール

Country Status (21)

Country Link
US (1) US7022708B2 (cg-RX-API-DMAC7.html)
EP (1) EP1556037B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006505559A (cg-RX-API-DMAC7.html)
KR (1) KR20050073560A (cg-RX-API-DMAC7.html)
CN (1) CN1309384C (cg-RX-API-DMAC7.html)
AR (1) AR041635A1 (cg-RX-API-DMAC7.html)
AT (1) ATE344030T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003283265B2 (cg-RX-API-DMAC7.html)
BR (1) BR0315317A (cg-RX-API-DMAC7.html)
CA (1) CA2501172A1 (cg-RX-API-DMAC7.html)
DE (1) DE60309498T2 (cg-RX-API-DMAC7.html)
ES (1) ES2274285T3 (cg-RX-API-DMAC7.html)
GT (1) GT200300226A (cg-RX-API-DMAC7.html)
MX (1) MXPA05004128A (cg-RX-API-DMAC7.html)
PA (1) PA8586401A1 (cg-RX-API-DMAC7.html)
PE (1) PE20040691A1 (cg-RX-API-DMAC7.html)
PL (1) PL376479A1 (cg-RX-API-DMAC7.html)
RU (1) RU2324693C2 (cg-RX-API-DMAC7.html)
TW (1) TW200418456A (cg-RX-API-DMAC7.html)
UY (1) UY28026A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004035047A1 (cg-RX-API-DMAC7.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2294932C2 (ru) * 2001-06-07 2007-03-10 Ф.Хоффманн-Ля Рош Аг Новые производные индола со сродством к рецептору 5-ht6
AR039127A1 (es) 2002-03-27 2005-02-09 Glaxo Group Ltd Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento
NZ544331A (en) 2003-07-22 2010-03-26 Arena Pharm Inc Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
US7767689B2 (en) 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
US7601840B2 (en) 2004-03-15 2009-10-13 Ptc Therapeutics, Inc. Carboline derivatives useful in the inhibition of angiogenesis
US8076352B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
US8076353B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
EA200700243A1 (ru) 2004-07-14 2007-08-31 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы лечения гепатита с
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
EP1781289A1 (en) 2004-07-22 2007-05-09 PTC Therapeutics, Inc. Thienopyridines for treating hepatitis c
US7713954B2 (en) * 2004-09-30 2010-05-11 Roche Palo Alto Llc Compositions and methods for treating cognitive disorders
EP1799306B1 (en) 2004-09-30 2011-02-23 F. Hoffmann-La Roche AG Compositions and methods for treating cognitive disorders
US7998981B2 (en) * 2005-08-12 2011-08-16 Suven Life Sciences Limited Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands
CA2619010C (en) * 2005-08-15 2013-10-01 Wyeth Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
US7923566B2 (en) 2005-08-16 2011-04-12 Suven Life Sciences Limited Alternative process for the preparation of losartan
JP2009523734A (ja) * 2006-01-13 2009-06-25 ワイス 5−ヒドロキシトリプタミン受容体のためのリガンドとしてのスルホニル置換された1h−インドール
MX2009004947A (es) * 2006-11-09 2009-05-19 Hoffmann La Roche Arilsulfonil-pirrolidinas como inhibidores 5-hidroxitriptaminas6 (5-ht6).
JP5208963B2 (ja) 2007-01-10 2013-06-12 エフ.ホフマン−ラ ロシュ アーゲー キマーゼ阻害剤としてのスルホンアミド誘導体
CA2703157C (en) 2007-10-26 2013-02-05 Suven Life Sciences Limited Amino arylsulfonamide compounds and their use as 5-ht6 ligands
EP2254564A1 (en) 2007-12-12 2010-12-01 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US8318725B2 (en) 2008-09-17 2012-11-27 Suven Life Sciences Limited Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
WO2011044134A1 (en) * 2009-10-05 2011-04-14 Albany Molecular Research, Inc. Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
AU2012207335A1 (en) 2011-01-19 2013-07-25 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
US9801863B2 (en) 2012-04-16 2017-10-31 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
CA2870666A1 (en) * 2012-04-16 2013-10-24 Case Western Reserve University Compositions and methods of modulating 15-pgdh activity
CN104276993B (zh) * 2013-07-12 2019-03-15 广东东阳光药业有限公司 吲哚衍生物及其在药物上的应用
CA2927730A1 (en) 2013-10-15 2015-05-07 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
CN104557726B (zh) * 2013-10-19 2019-05-24 广东东阳光药业有限公司 芳杂环类衍生物及其在药物上的应用
CN104725295B (zh) * 2013-12-20 2019-05-24 广东东阳光药业有限公司 芳杂环类衍生物及其在药物上的应用
AU2015286049B2 (en) 2014-07-08 2018-03-01 Sunshine Lake Pharma Co., Ltd. Aromatic heterocyclic derivatives and pharmaceutical applications thereof
JP2018516992A (ja) 2015-06-12 2018-06-28 アクソファント サイエンシーズ ゲーエムベーハーAxovant Sciences Gmbh レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
CN108472285A (zh) 2015-07-15 2018-08-31 阿速万科学有限责任公司 用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物
EP3548035A4 (en) 2016-11-30 2020-07-22 Case Western Reserve University COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
CN110573154A (zh) 2017-02-06 2019-12-13 卡斯西部储备大学 调节短链脱氢酶活性的组合物和方法
CN109232362B (zh) * 2017-07-10 2022-12-27 广东东阳光药业有限公司 芳杂环类衍生物及其在药物上的应用
WO2020106998A1 (en) 2018-11-21 2020-05-28 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
AU2021224268A1 (en) 2020-02-21 2022-09-15 Case Western Reserve University Compositions and methods for treating renal injury
SMT202500447T1 (it) 2021-11-02 2026-01-12 Flare Therapeutics Inc Agonisti inversi di pparg e loro usi

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116732D0 (en) 1991-08-02 1991-09-18 Fujisawa Pharmaceutical Co Indole derivatives
FR2729144A1 (fr) 1995-01-06 1996-07-12 Smithkline Beecham Lab Nouvelles diamines, leur procede de preparation et leur utilisation en tant que medicaments et notamment en tant qu' agents anti-arythmiques
DZ2376A1 (fr) 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
IL133870A0 (en) 1997-07-11 2001-04-30 Smithkline Beecham Plc Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
WO2000058304A1 (en) 1999-03-26 2000-10-05 Shionogi & Co., Ltd. Heterocyclic sulfonamide derivatives
WO2001064642A2 (en) 2000-02-29 2001-09-07 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor xa
KR100823908B1 (ko) * 2000-10-20 2008-04-21 바이오비트럼 에이비(피유비엘) 2-, 3-, 4-, 또는 5-치환-n1-(벤젠술포닐)인돌 및 이의치료 용도
ES2271124T3 (es) * 2000-11-24 2007-04-16 Smithkline Beecham Plc Compuestos indolil-sulfonilicos utiles en el tratamiento de trastornos del snc.
CN1321110C (zh) * 2001-06-15 2007-06-13 弗·哈夫曼-拉罗切有限公司 具有5-ht6受体亲和力的4-哌嗪基吲哚衍生物
JP4390698B2 (ja) * 2002-06-05 2009-12-24 エフ.ホフマン−ラ ロシュ アーゲー Cns障害の処置のための5−ht6レセプターモジュレーターとしての1−スルホニル−4−アミノアルコキシインドール誘導体
JP4754821B2 (ja) 2002-06-20 2011-08-24 プロキシマゲン・リミテッド 肥満症、ii型糖尿病およびcns障害の治療に有用な新規化合物
PL376022A1 (en) * 2002-09-17 2005-12-12 F.Hoffmann-La Roche Ag 2,4-substituted indoles and their use as 5-ht6 modulators

Similar Documents

Publication Publication Date Title
RU2005115115A (ru) 4-пиперазинилбензолсульфонилиндолы, характеризующиеся сродством к рецептору 5-нт6
PE20081263A1 (es) DERIVADOS DE 4-(2-AMINO-1-HIDROXIETIL)FENOL COMO AGONISTAS DEL RECEPTOR ß2 ADRENERGICO
CN1993323B (zh) 吲哚,吲唑或二氢吲哚衍生物
JP2012522847A5 (cg-RX-API-DMAC7.html)
JP2011500696A5 (cg-RX-API-DMAC7.html)
CA2288662A1 (en) Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
JP2011503120A5 (cg-RX-API-DMAC7.html)
ES2282495T3 (es) Uso de derivados de indol e indolino en el tratamiento de la obesidad o para la reduccion de consumo de alimento.
JP2007500155A5 (cg-RX-API-DMAC7.html)
CA2702482A1 (en) Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
TW200404778A (en) Novel compounds
JP2009534471A5 (cg-RX-API-DMAC7.html)
JP2004524301A5 (cg-RX-API-DMAC7.html)
JP2007504160A5 (cg-RX-API-DMAC7.html)
JP2004501962A5 (cg-RX-API-DMAC7.html)
RU2005136355A (ru) Производные сульфонамида, их получение и применение в качестве лекарственных средств
JP2005500345A5 (cg-RX-API-DMAC7.html)
JP2012255002A5 (cg-RX-API-DMAC7.html)
JP2007502265A5 (cg-RX-API-DMAC7.html)
JP2006525297A5 (cg-RX-API-DMAC7.html)
JP5575357B2 (ja) 組織因子産生抑制剤
JP2008517020A5 (cg-RX-API-DMAC7.html)
JP2005517665A5 (cg-RX-API-DMAC7.html)
JP2009541472A5 (cg-RX-API-DMAC7.html)
JP2009501745A5 (cg-RX-API-DMAC7.html)